Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Essai de phase 2, randomisé comparant l’efficacité d’une chimiothérapie de type VR-CAP (bortézomib, rituximab, cyclophosphamide, doxorubicine et prednisone) à une chimiothérapie de type R-CHOP (rituximab, cyclophosphamide, doxorubicine, vincristine et prednisone), chez des patients ayant un lymphome diffus à grandes cellules B. [essai clos aux inclusions] https://kusajili.com:443/Trial/yBp82tqIIkmzSabzRQ2XmQ%24essai-de-phase-2-randomise-comparant-lefficacite-dune-chimiotherapie-de-type-vr-cap-bortezomib-rituximab-cyclophosphamide-doxor
I have read and accept the terms of use of the site and the Privacy Policy
Send your message